Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#141 / 200 Total
KRRO - Korro Bio Inc. - Stock Price Chart
TickerKRRO [NASD, RUT]
CompanyKorro Bio Inc.
CountryUSA
IndustryBiotechnology
Market Cap344.55MEPS (ttm)-25.49
P/E-EPS this Y82.24%
Forward P/E-EPS next Y-3.86%
PEG-EPS past 5Y-11.67%
P/S-EPS next 5Y-
P/B1.74EPS Q/Q83.89%
Dividend-Sales Q/Q-
Insider Own36.47%Inst Own62.88%
Insider Trans5.56%Inst Trans-28.19%
Short Float4.99%EarningsAug 13/a
Analyst Recom1.00Target Price123.75
Avg Volume86.55K52W Range4.57 - 97.91
Today 08:00AM Korro to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-28-24 08:00AM Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors (GlobeNewswire)
Aug-27-24 08:00AM Korro to Participate in Upcoming September Investor and Scientific Conferences (GlobeNewswire)
Aug-13-24 04:01PM Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire) +9.21%
Jul-01-24 08:00AM Korro Joins the Russell 2000 , Russell 3000 , and Russell Microcap Indexes (GlobeNewswire)
Jun-25-24 12:53PM KRRO Stock Earnings: Korro Bio Beats EPS for Q4 2023 (InvestorPlace)
May-30-24 04:01PM Korro to Participate in Upcoming June Investor and Scientific Conferences (GlobeNewswire)
May-20-24 02:30PM Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference (GlobeNewswire)
May-14-24 10:55PM KRRO Stock Earnings: Korro Bio Beats EPS for Q1 2024 (InvestorPlace) +5.43%
04:01PM Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer (GlobeNewswire)
IZEA - IZEA Worldwide Inc - Stock Price Chart
TickerIZEA [NASD]
CompanyIZEA Worldwide Inc
CountryUSA
IndustryInternet Content & Information
Market Cap37.83MEPS (ttm)-0.56
P/E-EPS this Y-24.44%
Forward P/E-EPS next Y26.79%
PEG-EPS past 5Y30.03%
P/S1.15EPS next 5Y10.00%
P/B0.62EPS Q/Q-100.45%
Dividend-Sales Q/Q-14.92%
Insider Own24.37%Inst Own7.96%
Insider Trans47.02%Inst Trans-15.76%
Short Float0.39%EarningsAug 14/a
Analyst Recom1.00Target Price8.75
Avg Volume26.76K52W Range1.83 - 3.60
Today 10:00AM IZEA Worldwide, Inc. and GP Investments, Ltd. Partner on a New Value Creation Plan (GlobeNewswire) +7.48%
Sep-09-24 04:05PM IZEA Appoints Digital Leader Patrick Venetucci as Chief Executive Officer (GlobeNewswire)
Aug-29-24 10:00AM IZEA's IZZY Influencer Marketing AI Assistant Now Available in IZEA Flex Platform (GlobeNewswire)
Aug-22-24 11:00AM IZEA Report Finds 85% of China Consumers Have Purchased Products After Seeing Influencers Use Them (GlobeNewswire)
Aug-20-24 10:00AM IZEA Report Finds 46% of Social Media Users Ages 18-60 Have Changed Their Political Opinions Due to Influencer Content (GlobeNewswire)
Aug-19-24 11:00AM IZEA Flex Named Best Influencer Marketing Platform in 2024 MarTech Breakthrough Awards (GlobeNewswire) -6.30%
Aug-15-24 11:00AM IZEA Welcomes Justin Teo as Country Manager for China (GlobeNewswire) +6.76%
Aug-14-24 04:01PM IZEA Reports Q2 2024 Revenue of $9.1 Million (GlobeNewswire) -7.59%
Aug-05-24 11:00AM IZEA Wins Three Stevie Awards Recognizing Its Remote Workplace, Leaders (GlobeNewswire)
Jul-31-24 10:00AM IZEA Announces Q2 2024 Earnings Results Conference Call (GlobeNewswire)
ACRV - Acrivon Therapeutics Inc - Stock Price Chart
TickerACRV [NASD, RUT]
CompanyAcrivon Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap256.59MEPS (ttm)-2.77
P/E-EPS this Y11.18%
Forward P/E-EPS next Y-10.84%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.19EPS Q/Q17.86%
Dividend-Sales Q/Q-
Insider Own29.99%Inst Own68.94%
Insider Trans33.93%Inst Trans-
Short Float4.67%EarningsAug 13/b
Analyst Recom1.20Target Price22.00
Avg Volume90.83K52W Range3.19 - 11.90
Today 08:00AM Acrivon Therapeutics to Present at the Cantor Global Healthcare Conference (GlobeNewswire)
Sep-09-24 07:00AM Acrivon Therapeutics to Host Virtual Investor Event to Review Positive Phase 2 Clinical Data of ACR-368 Presented at ESMO and Pipeline Progress, Including Clinical Candidate ACR-2316 (GlobeNewswire)
Aug-15-24 09:40AM Are Medical Stocks Lagging Acrivon Therapeutics, Inc. (ACRV) This Year? (Zacks)
Aug-13-24 08:00AM Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
Jun-21-24 09:40AM Is Acrivon Therapeutics, Inc. (ACRV) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jun-05-24 09:40AM Is Acrivon Therapeutics, Inc. (ACRV) Outperforming Other Medical Stocks This Year? (Zacks)
May-29-24 08:00AM Acrivon Therapeutics to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-28-24 09:47AM Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock (Zacks)
May-20-24 09:40AM Has Acrivon Therapeutics, Inc. (ACRV) Outpaced Other Medical Stocks This Year? (Zacks)
May-14-24 01:54PM ACRV Stock Earnings: Acrivon Therapeutics Beats EPS for Q1 2024 (InvestorPlace)
ICCC - Immucell Corp. - Stock Price Chart
TickerICCC [NASD]
CompanyImmucell Corp.
CountryUSA
IndustryBiotechnology
Market Cap31.32MEPS (ttm)-0.52
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-11.98%
P/S1.35EPS next 5Y-
P/B1.34EPS Q/Q-10.11%
Dividend-Sales Q/Q54.92%
Insider Own39.13%Inst Own14.65%
Insider Trans0.00%Inst Trans-0.83%
Short Float0.05%EarningsAug 13/a
Analyst Recom-Target Price-
Avg Volume30.17K52W Range3.50 - 5.64
Aug-13-24 04:05PM ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 (GlobeNewswire)
Aug-07-24 04:05PM ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 (GlobeNewswire)
Jul-09-24 04:05PM ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 (GlobeNewswire)
Jun-05-24 04:05PM ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain (GlobeNewswire)
Jun-04-24 04:05PM ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-14-24 04:05PM ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 (GlobeNewswire) -10.89%
May-08-24 01:00PM ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024 (GlobeNewswire)
Apr-09-24 04:05PM ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 (GlobeNewswire)
Feb-29-24 08:25AM ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 04:05PM ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 (GlobeNewswire)
MGOL - MGO Global Inc - Stock Price Chart
TickerMGOL [NASD]
CompanyMGO Global Inc
CountryUSA
IndustryAdvertising Agencies
Market Cap6.63MEPS (ttm)-3.46
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.28EPS next 5Y-
P/B2.29EPS Q/Q-43.84%
Dividend-Sales Q/Q-26.93%
Insider Own64.56%Inst Own0.54%
Insider Trans0.00%Inst Trans-
Short Float24.45%Earnings-
Analyst Recom-Target Price-
Avg Volume2.95M52W Range1.90 - 18.30
Aug-22-24 09:01AM Heidmar, Inc. Advances Business Combination With MGO Global Inc. With Confidential Submission of Draft Registration Statement, Including Preliminary Prospectus and Proxy Statement (ACCESSWIRE) -12.81%
Aug-20-24 08:30AM MGO Global Reports Second Quarter 2024 Financial Results (ACCESSWIRE) -14.39%
Jul-16-24 08:30AM MGO Global Releases Preliminary Second Quarter 2024 Results and Comments on Key Business Highlights (ACCESSWIRE)
Jul-12-24 08:01PM MGO Global Announces Reverse Stock Split (ACCESSWIRE)
Jun-24-24 01:52PM MGOL Stock Earnings: MGO Global Reported Results for Q1 2024 (InvestorPlace)
Jun-21-24 07:52AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) -5.17%
Jun-20-24 02:51PM 3 Penny Stocks Ready to Explode Into Dollar Signs by 2028 (InvestorPlace) +63.39%
11:20AM NKLA Stock Plunges as Nikola Announces 1-for-30 Reverse Split (InvestorPlace)
11:00AM Why Is MGO Global (MGOL) Stock Up 133% Today? (InvestorPlace)
08:30AM Heidmar, Inc., a Global Leader in Crude Oil and Refined Petroleum Marine Transportation Services, Agrees to Business Combination with Nasdaq-Listed MGO Global Inc (ACCESSWIRE)
LWAY - Lifeway Foods, Inc. - Stock Price Chart
TickerLWAY [NASD, RUT]
CompanyLifeway Foods, Inc.
CountryUSA
IndustryPackaged Foods
Market Cap301.57MEPS (ttm)0.90
P/E22.76EPS this Y30.67%
Forward P/E14.88EPS next Y39.80%
PEG2.28EPS past 5Y-
P/S1.71EPS next 5Y10.00%
P/B4.44EPS Q/Q18.98%
Dividend-Sales Q/Q25.30%
Insider Own68.98%Inst Own19.39%
Insider Trans-2.65%Inst Trans-4.26%
Short Float8.66%EarningsAug 13/b
Analyst Recom1.00Target Price26.50
Avg Volume168.43K52W Range9.06 - 28.61
Sep-09-24 05:00PM Lifeway Foods Sponsors Charity Miles to Support Mental Health (PR Newswire) +6.13% -6.47%
Sep-06-24 10:13AM Lifeway Foods Inc (LWAY) Stock: A Bull Case Theory (Insider Monkey)
Sep-04-24 12:45PM 3 Reasons Growth Investors Will Love Lifeway (LWAY) (Zacks)
Sep-03-24 04:18PM Lifeway Foods to Participate in the 8th Annual Lake Street Best Ideas Growth Conference (PR Newswire)
Sep-02-24 09:40AM Are Consumer Staples Stocks Lagging Lifeway Foods (LWAY) This Year? (Zacks)
Aug-30-24 12:00PM Lifeway Foods (LWAY) Is Up 3.44% in One Week: What You Should Know (Zacks)
Aug-20-24 12:39PM Lifeway Foods Organic Strawnana ProBugs Whole Milk Kefir Selected as a Good Housekeeping 2024 Parenting Award Winner (PR Newswire)
Aug-19-24 05:00PM Insider Sale: CFO Eric Hanson Sells 5,546 Shares of Lifeway Foods Inc (LWAY) (GuruFocus.com) +6.34%
12:45PM Here is Why Growth Investors Should Buy Lifeway (LWAY) Now (Zacks)
Aug-16-24 07:51AM Lifeway Foods family feud heats up as shareholders push CEO to resign (Food Dive)
LPCN - Lipocine Inc - Stock Price Chart
TickerLPCN [NASD]
CompanyLipocine Inc
CountryUSA
IndustryBiotechnology
Market Cap21.40MEPS (ttm)-1.62
P/E-EPS this Y70.70%
Forward P/E-EPS next Y-1.09%
PEG-EPS past 5Y19.47%
P/S2.76EPS next 5Y-
P/B1.01EPS Q/Q15.94%
Dividend-Sales Q/Q-
Insider Own2.91%Inst Own9.94%
Insider Trans0.00%Inst Trans-63.19%
Short Float2.72%EarningsAug 08/b
Analyst Recom1.00Target Price33.00
Avg Volume47.52K52W Range2.31 - 11.79
Sep-05-24 08:00AM Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek (PR Newswire)
Aug-27-24 08:00AM Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference (PR Newswire)
Aug-08-24 08:00AM Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024 (PR Newswire) -12.90%
06:32AM Lipocine: Q2 Earnings Snapshot (Associated Press Finance)
Jun-25-24 08:00AM Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study (PR Newswire) -12.37%
Jun-10-24 08:00AM Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024 (PR Newswire) +6.12%
Jun-06-24 08:50AM Lipocine (LPCN) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
May-28-24 06:10AM 7 Penny Biotech Stocks to Triple Your Investment (InvestorPlace)
May-21-24 08:50AM Here's Why Momentum in Lipocine (LPCN) Should Keep going (Zacks)
May-09-24 01:53PM LPCN Stock Earnings: Lipocine Beats EPS for Q1 2024 (InvestorPlace) +8.04%
XCUR - Exicure Inc - Stock Price Chart
TickerXCUR [NASD]
CompanyExicure Inc
CountryUSA
IndustryBiotechnology
Market Cap3.10MEPS (ttm)-4.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y33.58%
P/S6.19EPS next 5Y-
P/B1.92EPS Q/Q89.85%
Dividend-Sales Q/Q-
Insider Own48.13%Inst Own2.95%
Insider Trans0.00%Inst Trans-
Short Float4.17%EarningsMay 16/a
Analyst Recom3.00Target Price10.00
Avg Volume548.14K52W Range1.46 - 4.75
Sep-09-24 06:53PM Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation (Business Wire)
Aug-26-24 09:08AM Exicure, Inc. Announces 1-for-5 Reverse Stock Split (Business Wire) -9.52%
Aug-19-24 10:31AM Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting (Business Wire) +9.83%
Aug-15-24 10:31AM Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting (Business Wire)
Aug-13-24 04:01PM Exicure, Inc. Reports Second Quarter 2024 Financial Results (Business Wire) -25.57%
Aug-08-24 04:27PM Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics (Business Wire) +6.48%
Aug-02-24 07:34AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) +33.76%
Aug-01-24 04:01PM Exicure, Inc. Receives Positive Listing Determination from Nasdaq (Business Wire) +12.97%
Jul-26-24 07:36AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jun-17-24 09:53PM XCUR Stock Earnings: Exicure Reported Results for Q1 2024 (InvestorPlace)
GNLN - Greenlane Holdings Inc - Stock Price Chart
TickerGNLN [NASD]
CompanyGreenlane Holdings Inc
CountryUSA
IndustryTobacco
Market Cap3.17MEPS (ttm)-43.70
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y41.00%
P/S0.11EPS next 5Y-
P/B0.42EPS Q/Q97.86%
Dividend-Sales Q/Q-86.49%
Insider Own0.24%Inst Own3.50%
Insider Trans0.00%Inst Trans-
Short Float35.20%Earnings-
Analyst Recom3.00Target Price151.25
Avg Volume1.38M52W Range2.05 - 21.80
Sep-09-24 01:37PM Greenlane Receives $15 Million Grant for Western U.S. EV Charging Corridor (POWER Magazine)
Aug-27-24 08:30AM Greenlane to Present at National Investment Bankers Association (NIBA) Conference in Florida on September 5, 2024 (ACCESSWIRE) -5.12%
Aug-15-24 05:05AM Greenlane: Q2 Earnings Snapshot (Associated Press Finance) -22.38%
Aug-14-24 11:00AM Aegis Capital Corp. acted as Exclusive Placement Agent on a $6.5 Million Private Placement Priced At-the-Market for Greenlane Holdings, Inc. (NASDAQ: GNLN) (ACCESSWIRE) +67.83%
Aug-13-24 03:35PM Greenlane Announces Closing of $6.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE) -12.96%
08:00AM Greenlane Announces Purchases of Shares by Chief Executive Officer (ACCESSWIRE)
04:00AM Safe Supply Streaming Corp. (SPLY) Announces Landmark USA Expansion of Portfolio Company, Safety Strips Tech Corp., in Partnership with Greenlane Holdings, Inc. (Newsfile)
Aug-12-24 03:54PM Greenlane Announces Pricing of $6.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE) +365.40%
08:30AM Greenlane Announces Non-Binding Letter of Intent to be the Exclusive Distributor in the U.S. of Safety Strips, Inc.'s Fentanyl, Xylazine and Drink Spike Detection Test Strips (ACCESSWIRE)
Aug-06-24 08:30AM Greenlane's Vapor.com Named to USA Today's List of 'America's Top Online Retail Shops' in Recent Survey (ACCESSWIRE) +19.91%
IOVA - Iovance Biotherapeutics Inc - Stock Price Chart
TickerIOVA [NASD, RUT]
CompanyIovance Biotherapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.84BEPS (ttm)-1.68
P/E-EPS this Y31.97%
Forward P/E-EPS next Y44.22%
PEG-EPS past 5Y-8.25%
P/S86.55EPS next 5Y-
P/B3.62EPS Q/Q28.17%
Dividend-Sales Q/Q12969.75%
Insider Own20.12%Inst Own68.27%
Insider Trans0.00%Inst Trans-1.80%
Short Float24.48%EarningsAug 08/a
Analyst Recom1.50Target Price22.90
Avg Volume7.12M52W Range3.21 - 18.33
Sep-06-24 09:30AM This Is the Biggest Risk With Iovance Biotherapeutics Stock (Motley Fool)
Sep-03-24 05:00PM Iovance Biotherapeutics to Present at Upcoming Conferences (GlobeNewswire) -6.95%
Sep-02-24 06:15PM 3 Monster Biotech Stocks to Buy Before 2025 (Motley Fool)
Aug-27-24 04:36AM Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years? (Motley Fool)
Aug-16-24 05:00PM Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +6.57%
Aug-14-24 07:15AM This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock (Motley Fool) -5.87%
Aug-09-24 12:23PM Why Iovance Biotherapeutics Shares Are Soaring Today (Motley Fool) +24.94%
09:27AM Iovance (IOVA) Q2 Earnings Beat, Stock Up on Upbeat Sales View (Zacks)
Aug-08-24 05:30PM Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +8.32%
04:24PM Iovance Biotherapeutics: Q2 Earnings Snapshot (Associated Press Finance)
1⋯1011121314151617181920
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.